LeY CAR T cells (Peter MacCallum Cancer Centre)

N/A

Report date: 2024/07/18 11:12:52

Base Information

Drug NameLeY CAR T cells (Peter MacCallum Cancer Centre)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionLewis-Y antigen antagonists
TargetsLewis-Y antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeter Maccallum Cancer Centre, Australia
China Registration ClassN/A

Develop Information

Active CompaniesPeter Maccallum Cancer CentrePeter Maccallum Cancer Centre, Australia
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A